Cellectar Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cellectar Biosciences, Inc. on March 6, 2017. The filing serves to disclose a scheduled presentation by the company's President and CEO, Jim Caruso, at the 29th Annual Roth Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory disclosure regarding a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces an upcoming investor relations event.
Guidance, Outlook, and Management Commentary
Management has announced that CEO Jim Caruso will present at the 29th Annual Roth Conference on Wednesday, March 15, 2017, at 12:30 PM PT. The presentation will take place in the Yellow Salon 6 at The Ritz Carlton, Laguna Niguel, in Dana Point, California. A press release detailing this event is included as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the date and time of the Roth Conference presentation: March 15, 2017, at 12:30 PM PT.
- Confirm the location of the presentation: The Ritz Carlton, Laguna Niguel, Dana Point, California.
- Note that this filing contains no financial data; investors should refer to the company's most recent 10-K or 10-Q for financial metrics.